Iindaba

Kwisiqingatha sokuqala sowama-2022, ukuthunyelwa kwamanye amazwe kweemveliso zempilo ezifana namayeza aseKorea, izixhobo zonyango kunye nezinto zokuthambisa kufikelele kwinqanaba eliphezulu kakhulu. Izixhobo zokuxilonga i-COVID-19 kunye neegonyo ziyakonyusa ukuthunyelwa kwamanye amazwe.
Ngokutsho kweKorea Health Industry Development Institute (KHIDI), ukuthunyelwa kwamanye amazwe kweli shishini kufikelele kwi-$13.35 yeebhiliyoni kwisiqingatha sokuqala salo nyaka. Elo nani linyuke nge-8.5% ukusuka kwi-$12.3 yeebhiliyoni kwikota yonyaka ophelileyo kwaye lelona nani liphezulu kwisiqingatha sonyaka. Lirekhode ngaphezulu kwe-$13.15 yeebhiliyoni kwisiqingatha sesibini sowama-2021.
Ngokwemizi-mveliso, ukuthunyelwa kwamanye amazwe kwamayeza kufikelele kwi-US$4.35 yeebhiliyoni, kunyuke nge-45.0% ukusuka kwi-US$3.0 yeebhiliyoni kwixesha elifanayo ngo-2021. Ukuthunyelwa kwamanye amazwe kwezixhobo zonyango kufikelele kwi-USD 4.93 yeebhiliyoni, kunyuke nge-5.2% ngonyaka. Ngenxa yokuvalelwa eTshayina, ukuthunyelwa kwamanye amazwe kwezithambiso kwehla nge-11.9% ukuya kwi-USD4.06 yeebhiliyoni.
Ukukhula kokuthunyelwa kwamanye amazwe kwamayeza kuqhutywe zii-biopharmaceuticals kunye nee-vaccines. Ukuthunyelwa kwamanye amazwe kwamayeza e-biopharmaceuticals kufikelele kwi-1.68 yeebhiliyoni zeerandi, ngelixa ukuthunyelwa kwamanye amazwe kwamayeza efikelela kwi-780 yezigidi zeerandi. Zombini zenza i-56.4% yazo zonke ii-export zamayeza. Ngokukodwa, ukuthunyelwa kwamanye amazwe kwamayeza e-vaccines kunyuke nge-490.8% unyaka nonyaka ngenxa yokwanda kokuthunyelwa kwamanye amazwe kwamayeza e-COVID-19 avelisiweyo phantsi kwesivumelwano sokwenziwa.
Kwicandelo lezixhobo zonyango, ii-reagents zokuxilonga zithatha isabelo esikhulu, zifikelela kwi-$2.48 yeebhiliyoni, zinyuke nge-2.8% ukusuka kwixesha elifanayo ngo-2021. Ukongeza, ukuthunyelwa kwezixhobo zomfanekiso we-ultrasound ($390 yezigidi), izixhobo zokufakelwa (340 yezigidi) kunye nezixhobo ze-X-ray ($330 yezigidi) kuqhubeke nokukhula, ikakhulu e-US nase-China.